BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16004874)

  • 1. The crystal structure of coxsackievirus A21 and its interaction with ICAM-1.
    Xiao C; Bator-Kelly CM; Rieder E; Chipman PR; Craig A; Kuhn RJ; Wimmer E; Rossmann MG
    Structure; 2005 Jul; 13(7):1019-33. PubMed ID: 16004874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.
    Johansson ES; Xing L; Cheng RH; Shafren DR
    J Virol; 2004 Nov; 78(22):12603-12. PubMed ID: 15507647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.
    Newcombe NG; Johansson ES; Au G; Lindberg AM; Barry RD; Shafren DR
    J Virol; 2004 Feb; 78(3):1431-9. PubMed ID: 14722298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of coxsackievirus A21 with its cellular receptor, ICAM-1.
    Xiao C; Bator CM; Bowman VD; Rieder E; He Y; Hébert B; Bella J; Baker TS; Wimmer E; Kuhn RJ; Rossmann MG
    J Virol; 2001 Mar; 75(5):2444-51. PubMed ID: 11160747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review: rhinoviruses and their ICAM receptors.
    Bella J; Rossmann MG
    J Struct Biol; 1999 Dec; 128(1):69-74. PubMed ID: 10600561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection.
    Marlin SD; Staunton DE; Springer TA; Stratowa C; Sommergruber W; Merluzzi VJ
    Nature; 1990 Mar; 344(6261):70-2. PubMed ID: 1968231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model of the complex between the PfEMP1 malaria protein and the human ICAM-1 receptor.
    Bertonati C; Tramontano A
    Proteins; 2007 Nov; 69(2):215-22. PubMed ID: 17640071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand.
    Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4140-5. PubMed ID: 9539703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.
    Skelding KA; Barry RD; Shafren DR
    Breast Cancer Res Treat; 2009 Jan; 113(1):21-30. PubMed ID: 18256929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
    Hrebík D; Füzik T; Gondová M; Šmerdová L; Adamopoulos A; Šedo O; Zdráhal Z; Plevka P
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular receptor interactions of C-cluster human group A coxsackieviruses.
    Newcombe NG; Andersson P; Johansson ES; Au GG; Lindberg AM; Barry RD; Shafren DR
    J Gen Virol; 2003 Nov; 84(Pt 11):3041-3050. PubMed ID: 14573809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping a common interaction site used by Plasmodium falciparum Duffy binding-like domains to bind diverse host receptors.
    Howell DP; Levin EA; Springer AL; Kraemer SM; Phippard DJ; Schief WR; Smith JD
    Mol Microbiol; 2008 Jan; 67(1):78-87. PubMed ID: 18047571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of the two amino-terminal domains of human intercellular adhesion molecule-1 suggests how it functions as a rhinovirus receptor.
    Bella J; Kolatkar PR; Marlor CW; Greve JM; Rossmann MG
    Virus Res; 1999 Aug; 62(2):107-17. PubMed ID: 10507321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel role for decay-accelerating factor in coxsackievirus A21-mediated cell infectivity.
    Newcombe NG; Beagley LG; Christiansen D; Loveland BE; Johansson ES; Beagley KW; Barry RD; Shafren DR
    J Virol; 2004 Nov; 78(22):12677-82. PubMed ID: 15507656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nautilus pompilius hemocyanin: 9 A cryo-EM structure and molecular model reveal the subunit pathway and the interfaces between the 70 functional units.
    Gatsogiannis C; Moeller A; Depoix F; Meissner U; Markl J
    J Mol Biol; 2007 Nov; 374(2):465-86. PubMed ID: 17936782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus.
    Baggen J; Hurdiss DL; Zocher G; Mistry N; Roberts RW; Slager JJ; Guo H; van Vliet ALW; Wahedi M; Benschop K; Duizer E; de Haan CAM; de Vries E; Casasnovas JM; de Groot RJ; Arnberg N; Stehle T; Ranson NA; Thibaut HJ; van Kuppeveld FJM
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):397-402. PubMed ID: 29284752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination among rhinovirus serotypes for a variant ICAM-1 receptor molecule.
    Xiao C; Tuthill TJ; Bator Kelly CM; Challinor LJ; Chipman PR; Killington RA; Rowlands DJ; Craig A; Rossmann MG
    J Virol; 2004 Sep; 78(18):10034-44. PubMed ID: 15331736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma.
    Au GG; Lincz LF; Enno A; Shafren DR
    Br J Haematol; 2007 Apr; 137(2):133-41. PubMed ID: 17391493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
    Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
    J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.